Growing community of inventors

Sharon, MA, United States of America

Qing Sheng

Average Co-Inventor Count = 7.20

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Qing ShengSeth Alexander Ettenberg (2 patents)Qing ShengNicole Haubst (2 patents)Qing ShengXizhong Huang (2 patents)Qing ShengChristian Carsten Silvester Kunz (2 patents)Qing ShengWinfried Elis (2 patents)Qing ShengAndrew Paul Garner (2 patents)Qing ShengElizabeth Anne Reisinger Sprague (2 patents)Qing ShengRakesh K Jain (1 patent)Qing ShengDai Fukumura (1 patent)Qing ShengVasileios Askoxylakis (1 patent)Qing ShengGino B Ferraro (1 patent)Qing ShengDavid P Kodack (1 patent)Qing ShengSeth Ettenberg (1 patent)Qing ShengChristian Carsten Kunz (1 patent)Qing ShengQing Sheng (3 patents)Seth Alexander EttenbergSeth Alexander Ettenberg (11 patents)Nicole HaubstNicole Haubst (9 patents)Xizhong HuangXizhong Huang (8 patents)Christian Carsten Silvester KunzChristian Carsten Silvester Kunz (6 patents)Winfried ElisWinfried Elis (4 patents)Andrew Paul GarnerAndrew Paul Garner (4 patents)Elizabeth Anne Reisinger SpragueElizabeth Anne Reisinger Sprague (4 patents)Rakesh K JainRakesh K Jain (34 patents)Dai FukumuraDai Fukumura (5 patents)Vasileios AskoxylakisVasileios Askoxylakis (1 patent)Gino B FerraroGino B Ferraro (1 patent)David P KodackDavid P Kodack (1 patent)Seth EttenbergSeth Ettenberg (1 patent)Christian Carsten KunzChristian Carsten Kunz (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (3 from 3,923 patents)

2. The General Hospital Corporation (1 from 2,893 patents)

3. Massachusetts General Hospital Corporation (83 patents)


3 patents:

1. 10689459 - Treatment of breast cancer brain metastases

2. 10080800 - Antibodies for epidermal growth factor receptor 3 (HER3)

3. 9192663 - Antibodies for epidermal growth factor receptor 3 (HER3)

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/29/2025
Loading…